Linola Fett (Unsaturated Fatty Acids (C18 : 2))

Linola Fett, a topical fatty‑acid preparation, is applied to skin conditions that benefit from barrier support and moisturisation.

• Atopic dermatitis: helps reduce dryness and improve skin barrier function.
• Xerosis (dry skin): restores moisture and alleviates scaling.
• Minor irritant dermatitis: soothes inflammation and supports healing.

• Unsaturated fatty acids (C18:2) integrate into the stratum corneum lipid matrix, enhancing epidermal barrier integrity and reducing transepidermal water loss. By supplying essential polyunsaturated lipids, the preparation promotes normal skin cell differentiation and modulates inflammatory mediators, leading to improved hydration and reduced irritation.

Topical application of Linola Fett may be associated with local skin reactions.

Common Side Effects

• Mild erythema: transient redness at the application site.
• Pruritus: occasional itching.
• Burning sensation: brief discomfort during initial use.
• Dryness: paradoxical dryness if over‑applied.
• Contact dermatitis: allergic response to formulation components.

Serious or Rare Side Effects

• Severe allergic reaction: swelling, hives, or difficulty breathing.
• Persistent ulceration: non‑healing skin breakdown.
• Secondary infection: bacterial or fungal overgrowth at irritated sites.
• Systemic absorption effects: unlikely but reported in extensive damaged skin.

Before using Linola Fett, consider the following safety measures.

• Contraindication: Do not apply to broken or infected skin without medical advice.
• Allergy screening: Verify no known hypersensitivity to fatty acids or excipients.
• Pediatric use: Use only under supervision of a healthcare professional.
• Pregnancy and lactation: Consult a physician before use.
• Interaction with occlusive dressings: Avoid covering treated area unless directed.
• Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Linola Fett may interact with other topical agents or systemic conditions.

Major Interactions (Avoid)

• Concurrent use of potent topical corticosteroids: may mask irritation and delay detection of adverse reactions.
• Occlusive dressings over treated area: can increase absorption and risk of irritation.

Moderate Interactions (Monitor Closely)

• Other emollients containing similar fatty acids: may cause cumulative skin sensitisation.
• Systemic lipid‑lowering therapy: no direct interaction, but monitor skin response.
• Phototherapy: assess for increased photosensitivity when combined.